Institutional Ownership Halozyme Therapeutics, Inc. (HALO)
This table provides information about the institutional ownership of Halozyme Therapeutics, Inc. (HALO). We have compiled data on the 545 institutions that hold shares in the stock, with a total of 124 Million shares, which have been reported (via 13F filing form) to have a value of $7.23 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
17,619,937
shares
|
$1.03 Billion
0.02% of portfolio
|
Q2 2024
Reduced 3.41%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Feb 11, 2025 Q4 2024 |
13,281,714
shares
|
$774 Million
0.01% of portfolio
|
Q4 2024
Added 3.0%
|
|
|
State Street Corp
Boston, MA |
Feb 14, 2025 Q4 2024 |
7,184,636
shares
|
$419 Million
0.01% of portfolio
|
Q4 2024
Added 8.31%
|
|
|
Snyder Capital Management L P
San Francisco, CA |
Feb 14, 2025 Q4 2024 |
4,168,453
shares
|
$243 Million
4.34% of portfolio
|
Q4 2024
Added 2.59%
|
|
|
Bank Of America Corp
Charlotte, NC |
Feb 14, 2025 Q4 2024 |
3,448,387
shares
|
$201 Million
0.01% of portfolio
|
Q4 2024
Added 66.63%
|
|
|
Alliancebernstein L.P.
New York, NY |
Feb 12, 2025 Q4 2024 |
3,068,432
shares
|
$179 Million
0.05% of portfolio
|
Q4 2024
Reduced 9.97%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Feb 12, 2025 Q4 2024 |
3,064,072
shares
|
$179 Million
0.01% of portfolio
|
Q4 2024
Added 0.13%
|
|
|
Macquarie Group LTD
Australia, C3 |
Feb 14, 2025 Q4 2024 |
2,905,485
shares
|
$169 Million
0.16% of portfolio
|
Q4 2024
Reduced 3.5%
|
|
|
Jpmorgan Chase & CO
New York, NY |
Feb 12, 2025 Q4 2024 |
2,387,489
shares
|
$139 Million
0.01% of portfolio
|
Q4 2024
Reduced 16.66%
|
|
|
Invesco Ltd.
Atlanta, GA |
Feb 13, 2025 Q4 2024 |
2,374,422
shares
|
$138 Million
0.02% of portfolio
|
Q4 2024
Added 24.21%
|
|
|
Congress Asset Management CO
|
Jan 30, 2025 Q4 2024 |
1,959,736
shares
|
$114 Million
0.66% of portfolio
|
Q4 2024
Reduced 19.47%
|
|
|
Dimensional Fund Advisors LP
Austin, TX |
Feb 13, 2025 Q4 2024 |
1,933,560
shares
|
$113 Million
0.02% of portfolio
|
Q4 2024
Added 2.53%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Feb 11, 2025 Q4 2024 |
1,850,633
shares
|
$108 Million
0.01% of portfolio
|
Q4 2024
Reduced 6.28%
|
|
|
Northern Trust Corp
Chicago, IL |
Feb 14, 2025 Q4 2024 |
1,827,771
shares
|
$107 Million
0.01% of portfolio
|
Q4 2024
Added 8.66%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Feb 06, 2025 Q4 2024 |
1,783,177
shares
|
$104 Million
0.02% of portfolio
|
Q4 2024
Added 0.55%
|
|
|
Gw&K Investment Management, LLC
Boston, MA |
Feb 05, 2025 Q4 2024 |
1,745,641
shares
|
$102 Million
0.71% of portfolio
|
Q4 2024
Reduced 0.94%
|
|
|
Morgan Stanley
New York, NY |
Feb 14, 2025 Q4 2024 |
1,646,965
shares
|
$96 Million
0.01% of portfolio
|
Q4 2024
Added 0.71%
|
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
1,530,519
shares
|
$89.2 Million
0.02% of portfolio
|
Q4 2024
Reduced 0.56%
|
|
|
Arrow Mark Colorado Holdings LLC
Denver, CO |
Feb 14, 2025 Q4 2024 |
1,510,511
shares
|
$88 Million
1.09% of portfolio
|
Q4 2024
Reduced 24.87%
|
|
|
Artisan Partners Limited Partnership
Milwaukee, WI |
Feb 12, 2025 Q4 2024 |
1,373,089
shares
|
$80 Million
0.11% of portfolio
|
Q4 2024
Reduced 56.18%
|
|
|
Td Asset Management Inc
|
Feb 11, 2025 Q4 2024 |
1,372,134
shares
|
$80 Million
0.06% of portfolio
|
Q4 2024
Reduced 11.52%
|
|
|
Stephens Investment Management Group LLC
|
Jan 28, 2025 Q4 2024 |
1,346,957
shares
|
$78.5 Million
0.9% of portfolio
|
Q4 2024
Reduced 0.94%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Feb 14, 2025 Q4 2024 |
1,262,757
shares
|
$73.6 Million
0.01% of portfolio
|
Q4 2024
New holding
|
|
|
Norges Bank
Oslo, Q8 |
Feb 12, 2025 Q4 2024 |
1,256,104
shares
|
$73.2 Million
0.01% of portfolio
|
Q4 2024
New holding
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Feb 14, 2025 Q4 2024 |
1,218,326
shares
|
$71 Million
0.01% of portfolio
|
Q4 2024
Reduced 4.11%
|